Therapeutic Area | MeSH |
---|---|
skin and connective tissue diseases | D017437 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ACANYA | Bausch Health Companies | N-050819 RX | 2008-10-23 | 1 products, RLD, RS |
ONEXTON | Bausch Health Companies | N-050819 RX | 2014-11-24 | 1 products, RLD, RS |
DUAC | Stiefel Laboratories | N-050741 RX | 2002-08-26 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BENZAMYCIN | Bausch Health Companies | N-050557 RX | 1984-10-26 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CABTREO | Bausch Health Companies | N-216632 RX | 2023-10-20 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
10 acne med | C200263 | 2024-06-05 |
111 medco benzoyl peroxide | C200263 | 2023-12-12 |
2.5 acne med | C200263 | 2024-06-05 |
3 step acne system | OTC monograph final | 2018-02-22 |
30 day acne treatment kit | C200263 | 2024-11-04 |
5 acne med | C200263 | 2024-06-05 |
5 percent benzoyl peroxide cleanser | C200263 | 2023-11-10 |
ab skincare acne spot treatment | OTC monograph final | 2018-09-27 |
acanya | New Drug Application | 2020-09-30 |
acne vanishing gel-10% | OTC monograph final | 2020-01-23 |
Expiration | Code | ||
---|---|---|---|
BENZOYL PEROXIDE, EPSOLAY, GALDERMA LABS LP | |||
2025-04-22 | NP | ||
BENZOYL PEROXIDE / TRETINOIN, TWYNEO, GALDERMA LABS LP | |||
2024-07-26 | NC | ||
BENZOYL PEROXIDE / CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, ENCUBE | |||
2023-03-13 | CGT |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Benzoyl Peroxide, Epsolay, Galderma Labs Lp | |||
11628155 | 2040-12-27 | U-3356 | |
11426378 | 2040-08-18 | U-3356 | |
10933046 | 2040-02-19 | DP | U-3357 |
10945987 | 2040-02-19 | U-3356 | |
11541026 | 2040-02-19 | U-3356 | |
9687465 | 2032-11-27 | DP | U-3356 |
9868103 | 2028-08-08 | DP | U-3194, U-3356 |
Benzoyl Peroxide / Tretinoin, Twyneo, Galderma Labs Lp | |||
10420743 | 2038-07-12 | U-3194 | |
10653899 | 2030-12-30 | DP | U-3194 |
11071878 | 2030-12-30 | DP | |
8617580 | 2028-02-03 | DP | |
Benzoyl Peroxide / Clindamycin Phosphate, Acanya, Bausch | |||
8288434 | 2029-08-05 | DP | U-124, U-134, U-818, U-916, U-921, U-1033 |
8663699 | 2029-06-03 | U-124 | |
8895070 | 2029-06-03 | U-124 | |
9078870 | 2029-06-03 | DP | |
9504704 | 2029-06-03 | DP | U-124, U-134, U-818, U-916 |
9561208 | 2029-06-03 | DP | U-916 |
10137142 | 2029-06-03 | DP | U-916 |
10220049 | 2029-06-03 | DP | U-916 |
10624918 | 2029-06-03 | U-916 | |
Adapalene / Benzoyl Peroxide, Epiduo, Galderma Labs Lp | |||
8071644 | 2027-07-18 | DP | U-1078 |
8080537 | 2027-07-18 | U-1078 | |
8129362 | 2027-07-18 | U-1078 | |
8445543 | 2027-07-12 | U-1078 | |
7820186 | 2025-11-23 | DP | |
7964202 | 2024-09-01 | DP | U-1078 |
Adapalene / Benzoyl Peroxide, Epiduo Forte, Galderma Labs | |||
8703820 | 2023-03-12 | U-1078 | |
8729127 | 2023-03-12 | U-1078 | |
9381179 | 2023-03-12 | U-1078 | |
9387187 | 2023-03-12 | U-1078 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Acne vulgaris | D000152 | EFO_0003894 | L70 | — | — | 4 | 1 | 1 | 6 |
Migraine disorders | D008881 | EFO_0003821 | G43 | — | — | — | 1 | — | 1 |
Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | 1 | — | 1 |
Adiposity | D050154 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Macular degeneration | D008268 | EFO_0001365 | H35.30 | — | — | 2 | — | — | 2 |
Drug common name | Benzoyl peroxide |
INN | — |
Description | Benzoyl peroxide is a carbonyl compound. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | O=C(OOC(=O)c1ccccc1)c1ccccc1 |
PDB | — |
CAS-ID | 94-36-0 |
RxCUI | — |
ChEMBL ID | CHEMBL1200370 |
ChEBI ID | 82405 |
PubChem CID | 7187 |
DrugBank | DB09096 |
UNII ID | — |